We are a group of researchers dedicated to inventing novel mechanism underlying the progression of CKD and its complications such as cardiovascular diseases. We hope to translate these inventions novel therapies for CKD
- Dominic Raj, M.D. is a nephrologist and translational researcher. His research is focused on understanding the cause and consequence of inflammation in patients with chronic kidney disease through epidemiologic, basic science and translational studies.
- Dr. Anvesha Srivastava, Ph.D. is a postdoctoral fellow with expertise in molecular biology. She is a translational researcher with special interest in characterizing non-coding RNAs as therapeutic targets and biomarkers for diagnosis, prognosis, and stratification of kidney diseases.
- Esther Adegbulugbe is primary coordinator for RenaCARE, Vertex801 and APOLLO studies.
- Ana Pabalan, MD is primary coordinator for CARSK and TRACK studies.